PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Projet Retro-CI, a CDC-Ministry of Health and AIDS (MSLS) collaborative USG-funded project, functions as the national reference laboratory for HIV/AIDS while working to build a strong National Public Health Laboratory (LNSP). With FY 2012 funding, Retro-CI will continue its support to the tiered MSLS public health lab system and will strengthen the institutional capacity and coordination role of the national HIV, TB, and malaria programs in building sustainable national infrastructure, increasing managerial and technical workforce capacity, and expanding services to provide quality diagnostic testing, clinical lab monitoring of treatment, and surveillance.While building capacity at the national reference labs, Retro-CI will continue to provide HIV reference testing and quality assurance (QA) to support quality services within the national lab network. A major activity is the progressive transfer of competence and technologies to the designated national reference labs to provide the minimum package of HIV lab services at all levels nationwide.Retro-CIs technical assistance (TA) will support achievement of both PEPFAR country goals and national strategic plan goals. Working with the CDC Lab Coalition, University of Washington I-TECH, Institut Pasteur of Cote dIvoire and other central and regional labs, the LNSP, the regional research organization CRESAC, and relevant national programs, Retro-CI will reflect PEPFAR CIs strategic emphases through priority support for validation and implementation of the national laboratory strategic plan; human resource development; and accreditation plans and processes, including strengthening of local lab NGOs capacity to support accreditation.Vehicles: No project-specific vehicles have been or will be bought.
Projet Retro-CI, a CDC-Ministry of Health and AIDS (MSLS) collaborative USG-funded project, functions as the national reference laboratory for HIV/AIDS and supports building capacity of the national HIV, TB, and malaria programs; increasing lab managerial and technical workforce capacity; and expanding quality-assured diagnostic testing, clinical lab monitoring of treatment, and surveillance. FY 2012 funding in PDCS will support procurements, supervision and technical assistance for the diagnosis of 10,000 infants by PCR, as well as procurement of lab containers to be installed at two regional labs for the decentralization of the early infant diagnosis program.
Projet Retro-CI, a CDC-Ministry of Health and AIDS (MSLS) collaborative USG-funded project, functions as the national reference laboratory for HIV/AIDS while working to build a strong National Public Health Laboratory (LNSP). With FY 2012 funding, Retro-CI will continue its support to the tiered MSLS public health lab system and will strengthen the institutional capacity and coordination role of the national HIV, TB, and malaria programs in building sustainable national infrastructure, increasing managerial and technical workforce capacity, and expanding services to provide quality-assured diagnostic testing, clinical lab monitoring of treatment, and surveillance.Retro-CI has been charged by the National HIV/AIDS Care and Treatment Program (PNPEC) with evaluation and validation of national HIV testing algorithms, evaluation of new lab practices and technologies, and provision of support and guidance on lab policy issues. A major activity is the progressive transfer of competence and technologies to the designated national reference labs to provide the minimum package of HIV lab services at all levels nationwide.Retro-CIs technical assistance (TA) will support achievement of both PEPFAR country goals and national strategic plan goals. Working with the CDC Lab Coalition, University of Washington I-TECH, the LNSP, Institut Pasteur of Cote dIvoire and other central and regional labs, and relevant national programs, Retro-CI will reflect PEPFAR CIs strategic emphases through priority support for validation and implementation of the national laboratory strategic plan; human resource development; and accreditation plans and processes, including strengthening of local lab NGOs capacity to support accreditation.Retro-CI will continue to support the national HIV/AIDS program through TA, providing a platform for training of lab professionals and for routine HIV testing, and will serve as a back-up lab for PEPFAR clinical partners for about 6,000 patients. Retro-CI will coordinate PEPFAR-supported lab activities in collaboration with PNPEC and national lab institutions and will transfer expertise by providing TA to the lab network through training, supervision, and implementation of quality assurance programs under the leadership of LNSP.Retro-CI will work closely with the PNPEC for evaluation and effective implementation of point-of-care tests for CD4 count and viral load, such as PIMA machines. TA will be provided to PNPEC to decentralize early infant diagnosis (EID) of HIV to two regional labs and to improve the transport systems for samples and EID results. Working with the national association of lab technicians, Retro-CI will support continuing education on best laboratory practices.Working with the CDC Lab Coalition, Retro-CI will continue support for the national institution in charge of lab accreditation (CRESAC) and for implementation of the WHO-AFRO accreditation scheme, aiming to enroll five labs each year in addition to the three central labs to achieve Level 5 accreditation.Working with I-TECH, Retro-CI will continue implementation of an open-source lab information system and its extension to two other central labs (LNSP, IPCI) and six regional labs while developing local capacity to maintain the system.Retro-CI will continue support for the quantification and procurement of lab commodities to support the national HIV/AIDS program.
Projet Retro-CI, a CDC-Ministry of Health and AIDS (MSLS) collaborative USG-funded project, functions as the national reference laboratory for HIV/AIDS and supports building capacity of the national HIV, TB, and malaria programs; increasing lab managerial and technical workforce capacity; and expanding quality-assured diagnostic testing, clinical lab monitoring of treatment, and surveillance. FY 2012 funding in HVCT will support procurements, supervision and technical assistance for the testing of 1,000 patients as part of their initial biological assessment for ARV treatment. In addition, technical assistance will be provided for HIV testing involved in ANC surveys, the Demographic Health Survey, and operations research.
Projet Retro-CI, a CDC-Ministry of Health and AIDS (MSLS) collaborative USG-funded project, functions as the national reference laboratory for HIV/AIDS and supports building capacity of the national HIV, TB, and malaria programs; increasing lab managerial and technical workforce capacity; and expanding quality-assured diagnostic testing, clinical lab monitoring of treatment, and surveillance. FY 2012 funding in HTXS will support procurements and technical assistance in support of biological monitoring tests for 6,000 adults living with HIV and other lab services, as well as evaluation of new lab technologies.
